Old Web
English
Sign In
Acemap
>
Paper
>
Elimination of Cells from Patients with Different Subtypes of AML by Dual-Targeting Triplebody 33-16-123 (SPM-2)
Elimination of Cells from Patients with Different Subtypes of AML by Dual-Targeting Triplebody 33-16-123 (SPM-2)
2017
Todd A. Braciak
Nadja C. Fenn
Sarah Wildenhain
Christian Schiller
Claudia C. Roskopf
Ingo Schubert
Uwe Jacob
Karl-Peter Hopfner
Michael Aigner
Andreas Mackensen
Marion Subklewe
Karsten Spiekermann
Georg H. Fey
Fuat S. Oduncu
Keywords:
Immunology
Medicine
Oncology
Diabetes mellitus
Internal medicine
dual targeting
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]